X-ray computed tomography (CT) has shown an absolutely remarkable and impressive increase in its performance characteristics for many years - remarkable because the modality was declared dead in the 1980s, impressive because these developments seemed impossible to many, for technical and for physics reasons.
Combining multislice CT equipment with procedures used in nuclear medicine such as PET-CT (positron emission tomography) and SPECT-CT (single photon emission computed tomography) offers fascinating perspectives of capturing morphological image and functional diagnostics.
More sensitive dissemination tests are needed for patients with locoregionally recurrent (LRR) breast cancer, according to a paper by Dutch researchers published online by the European Journal of Cancer (Volume 40, Issue 10 , 7/2004).